JP2013023482A - 整腸作用組成物 - Google Patents
整腸作用組成物 Download PDFInfo
- Publication number
- JP2013023482A JP2013023482A JP2011160998A JP2011160998A JP2013023482A JP 2013023482 A JP2013023482 A JP 2013023482A JP 2011160998 A JP2011160998 A JP 2011160998A JP 2011160998 A JP2011160998 A JP 2011160998A JP 2013023482 A JP2013023482 A JP 2013023482A
- Authority
- JP
- Japan
- Prior art keywords
- octopus
- powder
- intestinal
- bacteria
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 230000033228 biological regulation Effects 0.000 title abstract description 4
- 241000238413 Octopus Species 0.000 claims abstract description 71
- 239000000843 powder Substances 0.000 claims abstract description 46
- 241000894006 Bacteria Species 0.000 claims abstract description 31
- 210000000936 intestine Anatomy 0.000 claims abstract description 9
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 4
- 230000003871 intestinal function Effects 0.000 claims 3
- 241000251468 Actinopterygii Species 0.000 abstract description 2
- 238000004108 freeze drying Methods 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 235000015170 shellfish Nutrition 0.000 abstract description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 244000005709 gut microbiome Species 0.000 description 9
- 229960003080 taurine Drugs 0.000 description 9
- 241000193403 Clostridium Species 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000238366 Cephalopoda Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000014102 seafood Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 108020000946 Bacterial DNA Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012453 sprague-dawley rat model Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241001562081 Ikeda Species 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091074665 OCTOPUS family Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【解決手段】整腸作用組成物は、タコ粉末を有効成分として含有し腸内の善玉菌を増加させる。好ましくは、タコ粉末は、タコ乾燥粉末である。さらに好ましくは、タコ乾燥粉末は、タコを凍結乾燥し粉末化したものである。
【選択図】図1
Description
タコ粉末を有効成分として含有し腸内の善玉菌を増加させる、
ことを特徴とする。
本実施例では、タコ粉末を実験動物の飼料に含有させ、給餌した場合に係る実施例について詳細に説明する。
タコにはタウリン(2−アミノエタンスルホン酸)が豊富に含まれていることが知られている。本参考例では、前述の実施例における腸内細菌叢への影響がタウリンによるものであるか否かを検証した。
Claims (5)
- タコ粉末を有効成分として含有し腸内の善玉菌を増加させる、
ことを特徴とする整腸作用組成物。 - 前記タコ粉末は、タコ乾燥粉末である、
ことを特徴とする請求項1に記載の整腸作用組成物。 - 前記タコ乾燥粉末は、タコを凍結乾燥し粉末化したものである、
ことを特徴とする請求項2に記載の整腸作用組成物。 - 前記タコ粉末は、マダコの粉末である、
ことを特徴とする請求項1乃至3のいずれか一項に記載の整腸作用組成物。 - 前記善玉菌がLactobacillales属の細菌である、
ことを特徴とする請求項1乃至4のいずれか一項に記載の整腸作用組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011160998A JP6019435B2 (ja) | 2011-07-22 | 2011-07-22 | 整腸用組成物および整腸用組成物を生産する方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011160998A JP6019435B2 (ja) | 2011-07-22 | 2011-07-22 | 整腸用組成物および整腸用組成物を生産する方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013023482A true JP2013023482A (ja) | 2013-02-04 |
JP6019435B2 JP6019435B2 (ja) | 2016-11-02 |
Family
ID=47782214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011160998A Active JP6019435B2 (ja) | 2011-07-22 | 2011-07-22 | 整腸用組成物および整腸用組成物を生産する方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6019435B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104155162A (zh) * | 2014-08-22 | 2014-11-19 | 威海出入境检验检疫局检验检疫技术中心 | 动物源基体药物及其代谢物残留冻干粉标准样品制备方法 |
ES2685586A1 (es) * | 2017-04-07 | 2018-10-10 | Eusebio ALCAZAR LIDUEÑA | Procesado de pulpo en polvo |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0170617B1 (ko) * | 1996-08-27 | 1999-02-01 | 윤영희 | 살충제용 조성물 |
JP2001151796A (ja) * | 1999-09-14 | 2001-06-05 | Suntory Ltd | 新規タキキニン関連ペプチドおよびその前駆体ポリペプチドならびにこれらをコードする遺伝子 |
-
2011
- 2011-07-22 JP JP2011160998A patent/JP6019435B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0170617B1 (ko) * | 1996-08-27 | 1999-02-01 | 윤영희 | 살충제용 조성물 |
JP2001151796A (ja) * | 1999-09-14 | 2001-06-05 | Suntory Ltd | 新規タキキニン関連ペプチドおよびその前駆体ポリペプチドならびにこれらをコードする遺伝子 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104155162A (zh) * | 2014-08-22 | 2014-11-19 | 威海出入境检验检疫局检验检疫技术中心 | 动物源基体药物及其代谢物残留冻干粉标准样品制备方法 |
ES2685586A1 (es) * | 2017-04-07 | 2018-10-10 | Eusebio ALCAZAR LIDUEÑA | Procesado de pulpo en polvo |
Also Published As
Publication number | Publication date |
---|---|
JP6019435B2 (ja) | 2016-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jha et al. | Probiotics (direct-fed microbials) in poultry nutrition and their effects on nutrient utilization, growth and laying performance, and gut health: A systematic review | |
Humam et al. | Effects of feeding different postbiotics produced by Lactobacillus plantarum on growth performance, carcass yield, intestinal morphology, gut microbiota composition, immune status, and growth gene expression in broilers under heat stress | |
Choi et al. | Dietary application of tannins as a potential mitigation strategy for current challenges in poultry production: A review | |
Roto et al. | An introduction to the avian gut microbiota and the effects of yeast-based prebiotic-type compounds as potential feed additives | |
Shi et al. | Bacillus subtilis H2 modulates immune response, fat metabolism and bacterial flora in the gut of grass carp (Ctenopharyngodon idellus) | |
Li et al. | Effects of fermented soybean meal supplementation on the growth performance and cecal microbiota community of broiler chickens | |
Nakata et al. | Inhibitory effects of laminaran and alginate on production of putrefactive compounds from soy protein by intestinal microbiota in vitro and in rats | |
Sotira et al. | Effects of tributyrin supplementation on growth performance, insulin, blood metabolites and gut microbiota in weaned piglets | |
Li et al. | Environmental microplastics exposure decreases antioxidant ability, perturbs gut microbial homeostasis and metabolism in chicken | |
Pogány Simonová et al. | Autochtonous strain Enterococcus faecium EF2019 (CCM7420), its bacteriocin and their beneficial effects in broiler rabbits—A review | |
Kober et al. | Immunomodulation potential of probiotics: a novel strategy for improving livestock health, immunity, and productivity | |
Vadopalas et al. | Pigs’ feed fermentation model with antimicrobial lactic acid bacteria strains combination by changing extruded soya to biomodified local feed stock | |
Du et al. | Enhancement of growth, survival, immunity and disease resistance in Litopenaeus vannamei, by the probiotic, Lactobacillus plantarum Ep-M17 | |
Park et al. | Effects of feeding Original XPC™ to broilers with a live coccidiosis vaccine under industrial conditions: Part 2. Cecal microbiota analysis | |
Huang et al. | Effects of clostridium butyricum and a bacteriophage cocktail on growth performance, serum biochemistry, digestive enzyme activities, intestinal morphology, immune responses, and the intestinal microbiota in rabbits | |
Śmiałek et al. | The use of probiotics in the reduction of Campylobacter spp. prevalence in poultry | |
Yang et al. | Effects of fenugreek seed extracts on growth performance and intestinal health of broilers | |
Schei et al. | Early gut fungal and bacterial microbiota and childhood growth | |
Ognik et al. | Oxidative and epigenetic changes and gut permeability response in early-treated chickens with antibiotic or probiotic | |
Liu et al. | Effect of niacin on growth performance, intestinal morphology, mucosal immunity and microbiota composition in weaned piglets | |
Chen et al. | Effects of hydrolysable tannin with or without condensed tannin on alfalfa silage fermentation characteristics and in vitro ruminal methane production, fermentation patterns, and microbiota | |
Servin Arce et al. | Modulation of the gut microbiota of Pacific white shrimp (Penaeus vannamei Boone, 1931) by dietary inclusion of a functional yeast cell wall‐based additive | |
Yang et al. | Effects of dietary fucoidan supplementation on serum biochemical parameters, small intestinal barrier function, and cecal microbiota of weaned goat kids | |
Liu et al. | Effect of dietary Clostridium butyricum supplementation on growth performance, intestinal barrier function, immune function, and microbiota diversity of Pekin ducks | |
Liu et al. | Effects of fermented Andrographis paniculata on growth performance, carcass traits, immune function, and intestinal health in Muscovy ducks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140718 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140718 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150616 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150810 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160112 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160314 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160809 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160907 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6019435 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |